Latest Insider Transactions at Eastman Chemical CO (EMN)
This section provides a real-time view of insider transactions for Eastman Chemical CO (EMN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of EASTMAN CHEMICAL CO to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of EASTMAN CHEMICAL CO's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
Stephen Glenn Crawford EVP, Manf. & Chf Sustain Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
9,869
+16.56%
|
-
|
|
Feb 14
2024
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
519
-10.48%
|
$42,558
$82.12 P/Share
|
|
Feb 14
2024
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
2,076
+29.53%
|
-
|
|
Feb 14
2024
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,338
-5.14%
|
$273,716
$82.12 P/Share
|
|
Feb 14
2024
|
Brad A Lich EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
13,352
+17.04%
|
-
|
|
Feb 14
2024
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,742
-4.01%
|
$142,844
$82.12 P/Share
|
|
Feb 14
2024
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
6,966
+13.81%
|
-
|
|
Feb 14
2024
|
Mark J Costa CEO & Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
13,134
-3.08%
|
$1,076,988
$82.12 P/Share
|
|
Feb 14
2024
|
Mark J Costa CEO & Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
52,535
+10.97%
|
-
|
|
Dec 01
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
SELL
Payment of exercise price or tax liability
|
Direct |
3,312
-24.03%
|
$281,520
$85.46 P/Share
|
|
Dec 01
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
BUY
Exercise of conversion of derivative security
|
Direct |
10,124
+42.35%
|
-
|
|
Dec 01
2023
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,233
-8.46%
|
$104,805
$85.46 P/Share
|
|
Dec 01
2023
|
Christopher Moore Killian SVP & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,062
+25.78%
|
-
|
|
Aug 01
2023
|
Adrian James Holt SVP, Chf HR Ofcr |
SELL
Open market or private sale
|
Direct |
1,935
-100.0%
|
$164,475
$85.64 P/Share
|
|
Aug 01
2023
|
Adrian James Holt SVP, Chf HR Ofcr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,935
+50.0%
|
$118,035
$61.51 P/Share
|
|
May 04
2023
|
Charles K. Stevens Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+21.69%
|
-
|
|
May 04
2023
|
Linnie M Haynesworth Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+48.09%
|
-
|
|
May 04
2023
|
Eric L Butler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+28.5%
|
-
|
|
May 04
2023
|
David W Raisbeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+3.25%
|
-
|
|
May 04
2023
|
James J /Ky Obrien Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+35.37%
|
-
|
|
May 04
2023
|
Julie Fasone Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,396
+9.52%
|
-
|
|
Apr 13
2023
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,576
-13.25%
|
$462,808
$83.38 P/Share
|
|
Apr 13
2023
|
Kellye L. Walker EVP, CLO & Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
18,701
+30.77%
|
-
|
|
Feb 28
2023
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
185
-10.34%
|
$15,725
$85.2 P/Share
|
|
Feb 28
2023
|
Michelle Renee Stewart Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
665
+27.09%
|
-
|
|
Feb 17
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Open market or private sale
|
Direct |
1,900
-39.77%
|
$163,400
$86.89 P/Share
|
|
Feb 15
2023
|
Mark J Costa CEO & Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
34,891
-8.53%
|
$3,105,299
$89.09 P/Share
|
|
Feb 15
2023
|
Mark J Costa CEO & Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
92,916
+18.52%
|
-
|
|
Feb 15
2023
|
Stephen Glenn Crawford EVP, Manf. & Chf Sustain Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
3,849
-8.81%
|
$342,561
$89.09 P/Share
|
|
Feb 15
2023
|
Stephen Glenn Crawford EVP, Manf. & Chf Sustain Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
14,035
+24.31%
|
-
|
|
Feb 15
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-14.86%
|
$74,226
$89.09 P/Share
|
|
Feb 15
2023
|
Julie A. Mc Alindon SVP, Regions & Chf SupChn Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
3,343
+37.34%
|
-
|
|
Feb 15
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
SELL
Payment of exercise price or tax liability
|
Direct |
1,076
-22.74%
|
$95,764
$89.09 P/Share
|
|
Feb 15
2023
|
Brian Travis Smith SVP, Add & Funct Prod |
BUY
Grant, award, or other acquisition
|
Direct |
3,597
+43.19%
|
-
|
|
Feb 15
2023
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
904
-8.92%
|
$80,456
$89.09 P/Share
|
|
Feb 15
2023
|
Christopher Moore Killian SVP & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
3,631
+26.37%
|
-
|
|
Feb 15
2023
|
Michelle Renee Stewart Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-17.34%
|
$21,004
$89.09 P/Share
|
|
Feb 15
2023
|
Michelle Renee Stewart Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
665
+32.82%
|
-
|
|
Feb 15
2023
|
William Thomas Mc Lain Jr. EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,044
-12.48%
|
$359,916
$89.09 P/Share
|
|
Feb 15
2023
|
William Thomas Mc Lain Jr. EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
14,519
+30.94%
|
-
|
|
Feb 15
2023
|
Brad A Lich EVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,471
-12.64%
|
$664,919
$89.09 P/Share
|
|
Feb 15
2023
|
Brad A Lich EVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
23,229
+28.21%
|
-
|
|
Oct 17
2022
|
Brian Travis Smith SVP, Add & Funct Prod |
SELL
Payment of exercise price or tax liability
|
Direct |
580
-33.82%
|
$42,340
$73.94 P/Share
|
|
Oct 17
2022
|
Brian Travis Smith SVP, Add & Funct Prod |
BUY
Exercise of conversion of derivative security
|
Direct |
1,715
+50.0%
|
-
|
|
Oct 17
2022
|
Christopher Moore Killian SVP & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
675
-9.48%
|
$49,275
$73.94 P/Share
|
|
Oct 17
2022
|
Christopher Moore Killian SVP & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,715
+19.4%
|
-
|
|
May 05
2022
|
Charles K. Stevens Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+22.22%
|
-
|
|
May 05
2022
|
David W Raisbeck Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+2.52%
|
-
|
|
May 05
2022
|
Julie Fasone Holder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,041
+8.06%
|
-
|
|
May 03
2022
|
Lucian Boldea Executive VP |
SELL
Open market or private sale
|
Direct |
10,500
-32.27%
|
$1,071,000
$102.86 P/Share
|